ACE system will be employed for Pain’s Mab production.
Chromos Molecular Systems inked a cell line development deal with Pain Therapeutics. It will engineer cell lines specific for the expression of a Mab for Pain Therapeutics using the ACE System.
Pain Therapeutics has the right to use the cell lines for scale up and manufacture of the Mab, following the cell line engineering phase of the agreement.
